MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 49 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,553 | -35.2% | 120,584 | -33.6% | 0.00% | -20.0% |
| Q2 2023 | $239,876 | -20.6% | 181,724 | -57.5% | 0.01% | -16.7% |
| Q1 2023 | $302,131 | +387.3% | 427,403 | +669.7% | 0.01% | +200.0% |
| Q2 2022 | $62,000 | -32.6% | 55,532 | -32.8% | 0.00% | 0.0% |
| Q1 2022 | $92,000 | -30.3% | 82,583 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $132,000 | -37.7% | 82,583 | -5.5% | 0.00% | -50.0% |
| Q3 2021 | $212,000 | -47.8% | 87,420 | -31.7% | 0.01% | -53.8% |
| Q2 2021 | $406,000 | -18.6% | 128,048 | -13.5% | 0.01% | -31.6% |
| Q1 2021 | $499,000 | +9.0% | 148,048 | +15.6% | 0.02% | +11.8% |
| Q4 2020 | $458,000 | +30.9% | 128,048 | -4.2% | 0.02% | -19.0% |
| Q3 2020 | $350,000 | – | 133,634 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |